Patient adherence and persistence with oral anticancer treatment

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Ca

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.3322/caac.20004PMID 19147869
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Medication compliance and persistence: terminology and definitions.

  2008cited by this paper
• CALGB 60104: Adherence with adjuvant capecitabine among women age 65 and older with early stage breast cancer treated on CALGB 49907

  2008cited by this paper
• Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer.

  2008cited by this paper
• Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer.

  2008cited by this paper
• Adherence to the immunomodulatory drugs for multiple sclerosis: contrasting factors affect stopping drug and missing doses

  2008cited by this paper
• 4–48 Early Discontinuation of Tamoxifen: A Lesson for Oncologists

  2008cited by this paper
• Early discontinuation of tamoxifen

  2007cited by this paper
• Oral Anticancer Drugs in the Elderly

  2007cited by this paper
• Mild-to-Moderate Ulcerative Colitis: Your Role in Patient Compliance and Health Care Costs

  2007cited by this paper
• Adherence to Endocrine Therapy for Breast Cancer

  2007cited by this paper
• Oral chemotherapy safety practices at US cancer centres: questionnaire survey

  2007cited by this paper
• Adolescent Adherence to Oral Therapy for Leukemia: A Focus Group Study

  2007cited by this paper
• A comparison of patient adherence and preference of packaging method for oral anticancer agents using conventional pill bottles versus daily pill boxes.

  2007cited by this paper
• Helping breast cancer patients adhere to oral adjuvant hormonal therapy regimens

  2007cited by this paper
• Patients' preference for administration of endocrine treatments by injection or tablets: results from a study of women with breast cancer.

  2006cited by this paper
• Adherence to tamoxifen over the five-year course

  2006cited by this paper
• Correction for errors in measuring adherence to prenatal multivitamin/mineral supplement use among low-income women.

  2006cited by this paper
• Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial.

  2006cited by this paper
• Assessing medication adherence from pharmacy records

  2006cited by this paper
• Do people with cancer comply with oral chemotherapy treatments?

  2006cited by this paper
• Centralized medical monitoring in phase III clinical trials: the National Surgical Adjuvant Breast and Bowel Project (NSABP) experience

  2006cited by this paper
• Pharmacokinetics, pharmacodynamics and adherence to oral topotecan in myelodysplastic syndromes: a Cancer and Leukemia Group B study

  2005cited by this paper
• Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.

  2005cited by this paper
• Intentional and non-intentional non-adherence to medication amongst breast cancer patients.

  2005cited by this paper
• Adherence to medication.

  2005cited by this paper
• Adherence to medication.

  2005influential reference
• Adherence beliefs among breast cancer patients taking tamoxifen.

  2005cited by this paper
• Interventions to enhance medication adherence.

  2005cited by this paper
• A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer*

  2004cited by this paper
• Switching to exemestane after 2-3 years of adjuvant tamoxifen prolongs disease-free survival, but not overall survival, in postmenopausal women surviving primary breast cancer, compared with continuous tamoxifen.

  2004cited by this paper
• Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands

  2004cited by this paper
• A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer.

  2004cited by this paper
• Pharmionics: research on what patients do with prescription drugs

  2004cited by this paper
• Measurement of patient compliance and the interpretation of randomized clinical trials

  2004cited by this paper
• Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor--positive breast cancer.

  2004cited by this paper
• Adherence to long-term therapies: evidence for action.

  2003cited by this paper
• Adherence to Long-Term Therapies: Evidence for Action

  2003cited by this paper
• Aromatase inhibitors in breast cancer.

  2003cited by this paper
• Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer.

  2003cited by this paper
• A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer

  2003cited by this paper
• A changing paradigm for cancer treatment: the advent of new oral chemotherapy agents.

  2003cited by this paper
• Oral cancer treatment: developments in chemotherapy and beyond

  2002cited by this paper
• Helping patients follow prescribed treatment: clinical applications.

  2002cited by this paper
• Adherence to therapy with oral antineoplastic agents.

  2002cited by this paper
• Interventions to enhance patient adherence to medication prescriptions: scientific review.

  2002cited by this paper
• Tamoxifen non-compliance: does it matter?

  2002cited by this paper
• A systematic review of the associations between dose regimens and medication compliance.

  2001cited by this paper
• Adjuvant tamoxifen: predictors of use, side effects, and discontinuation in older women.

  2001cited by this paper
• Feasibility of a novel weekday-on/weekend-off oral UFT schedule as postoperative adjuvant chemotherapy for colorectal cancer

  2000cited by this paper
• Medication noncompliance: what is the problem?

  2000cited by this paper
• Antiplatelet therapy: a perspective from cardiology.

  2000cited by this paper
• Expanding the roles of outpatient pharmacists: effects on health services utilisation, costs, and patient outcomes.

  2000cited by this paper
• Tamoxifen in the treatment of breast cancer.

  1998cited by this paper
• Tamoxifen as Adjuvant after Surgery for Breast Cancer and Tamoxifen or Placebo as Chemoprevention in Healthy Women: Different Compliance with Treatment

  1998cited by this paper
• Persistence of use of lipid-lowering medications: a cross-national study.

  1998cited by this paper
• Tamoxifen in the Treatment of Breast Cancer

  1998cited by this paper
• Profile of non-compliance in lymphoblastic leukaemia

  1997cited by this paper
• Patient compliance with prolonged oral altretamine treatment in relapsed ovarian cancer.

  1996cited by this paper
• Intracellular metabolites of mercaptopurine in children with lymphoblastic leukaemia: a possible indicator of non-compliance?

  1995cited by this paper
• Patterns of drug compliance with medications to be taken once and twice daily assessed by continuous electronic monitoring in primary care.

  1994cited by this paper
• Treatment compliance in childhood and adolescence

  1993cited by this paper
• Patient compliance with prolonged low-dose oral etoposide for small cell lung cancer.

  1993cited by this paper
• Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring.

  1993cited by this paper
• Therapeutic adherence to oral medication regimens by adolescents with cancer. II. Clinical and psychologic correlates.

  1992cited by this paper
• Patient compliance with oral chemotherapy as assessed by a novel electronic technique.

  1992cited by this paper
• Therapeutic adherence to oral medication regimens by adolescents with cancer. I. Laboratory assessment.

  1992cited by this paper
• Measurement of patient compliance and the interpretation of randomized clinical trials.

  1991cited by this paper
• The behavioral dynamics of clinical trials.

  1991cited by this paper
• Compliance and clinical trials.

  1991cited by this paper
• Patient noncompliance with self‐administered chemotherapy

  1990cited by this paper
• The natural history of medication compliance in a drug trial: Limitations of pill counts

  1989cited by this paper
• Time to stop counting the tablets?

  1989cited by this paper
• The influence of symptoms of disease and side effects of treatment on compliance with cancer therapy.

  1988cited by this paper
• Tamoxifen in the treatment of breast cancer.

  1988cited by this paper
• Compliance with oral drug therapy in patients with hematologic malignancy.

  1987cited by this paper
• Evaluation of a Novel Medication Aid, the Calendar Blister‐Pak, and its Effect on Drug Compliance in a Geriatric Outpatient Clinic

  1987cited by this paper
• Compliance of pediatric and adolescent cancer patients

  1986cited by this paper
• Overview of patient compliance with medication dosing: a literature review.

  1984cited by this paper
• Psychological correlates of compliance.

  1983cited by this paper
• Compliance with drug treatment.

  1981cited by this paper
• Dose-response effect of adjuvant chemotherapy in breast cancer.

  1981cited by this paper
• Compliance with drug treatment.

  1979cited by this paper
• A reliable method for evaluating drug compliance in children with cancer

  1979cited by this paper
• Manipulation of the therapeutic regimen to improve compliance: conceptions and misconceptions.

  1977cited by this paper
• The Health Belief Model and prediction of dietary compliance: a field experiment.

  1977cited by this paper
• Demonstration to medical students of placebo responses and non-drug factors.

  1972cited by this paper

• Predictors of Decision-Making Regarding Endocrine Therapy in Breast Cancer Survivors: A Systematic Review

  2026influential citation
• Medication adherence in a German cohort of patients with advanced or metastatic breast cancer: results of the BRE-BY-MED study

  2026cites this paper
• Home Medication Regimen Complexity in Newly Diagnosed Pediatric Oncology Patients.

  2025cites this paper
• COVID-19-Related Financial Hardship and Adherence to Adjuvant Endocrine Therapy Among Women With Early-Stage Breast Cancer.

  2025cites this paper
• "Development and validation of a web-based platform for streamlining chemotherapy management in oncology".

  2025cites this paper
• Benefit and safety of capecitabine after resection of biliary tract cancer: a real-world study with propensity score matching

  2025cites this paper
• Early Check-In Protocol: Identifying Medication Issues in Patients with Cancer at Health System Specialty Pharmacy

  2025cites this paper
• [THERANOVA-LIM: Improving access to information on oral treatments for patients and pharmacists].

  2025cites this paper
• Adherence to adjuvant endocrine therapy including GnRH-analogues and survival: a population-based cohort study

  2025cites this paper
• Psychometric properties of modified 10-item Medication Adherence Scale for cancer patients receiving chemotherapy: Self-report scale validation study.

  2025cites this paper
• Reconceptualizing Technology for Chronic Disease Management Activities in the Family: Supporting Collective Routines

  2025cites this paper
• Check the Impact of Mobile Health on Medication Adherence in Adolescents with Leukemia

  2025cites this paper
• Managing adherence, exposure, and toxicity in oral anticancer therapies

  2025cites this paper
• Role of pharmacists in adherence in oncology patients

  2024cites this paper
• A budget impact analysis of a digital monitoring solution in patients treated with oral anticancer agents: a medico-economic analysis of the randomized phase 3 CAPRI trial

  2024cites this paper
• Pharmacist-Led Video Consultation to Identify and Mitigate Drug Interactions Among Patients Initiating Oral Anticancer Drugs

  2024cites this paper
• Hesperidin Inhibits Oral Cancer Cell Growth via Apoptosis and Inflammatory Signaling-Mediated Mechanisms: Evidence From In Vitro and In Silico Analyses

  2024cites this paper
• Hospital pharmacists' perceived competence in providing care to oncology patients - (HoPP-CoP2).

  2024cites this paper
• Implantation of In Situ Gelling Systems for the Delivery of Chemotherapeutic Agents

  2024cites this paper
• Age and Late Recurrence in Young Patients With ER–Positive, ERBB2-Negative Breast Cancer

  2024cites this paper
• Medication Adherence and Self-Efficacy in Patients on Polypharmacy

  2024cites this paper
• Digital Solution to Support Medication Adherence and Self-Management in Patients with Cancer (SAMSON): Pilot Randomized Controlled Trial

  2024cites this paper
• AI-based big data analysis of user-generated content to understand adherence in oral hormone receptor-positive advanced breast cancer treatment: A literature review and patient-centered approach using natural language processing

  2024cites this paper
• Effectiveness of Short Message Service Support on Adherence to Chemotherapy Treatment among Patients Attending Cancer Treatment Facilities in Kenya

  2024cites this paper
• Dynamic Projection of Medication Nonpersistence and Nonadherence Among Patients With Early Breast Cancer

  2024cites this paper
• Medication adherence to oral chemotherapeutic agents: a qualitative study of patients' and cancer care professionals' perspectives

  2023cites this paper
• Facilitators and barriers to adherence to medical recommendations among adolescents with cancer: A systematic review

  2023cites this paper
• Factors associated with lenvatinib adherence in thyroid cancer and hepatocellular carcinoma

  2023cites this paper
• Adherence and quality of life in patients with chronic lymphocytic leukemia treated with oral antineoplastic drugs.

  2023cites this paper
• [Translate article] Adherence and quality of life in patients with chronic lymphocytic leukemia treated with oral antineoplastic drugs.

  2023cites this paper
• Adherence to Oral Chemotherapy in Acute Lymphoblastic Leukemia during Maintenance Therapy in Children, Adolescents, and Young Adults: A Systematic Review

  2023cites this paper
• S-1 and 5-Fluorouracil-related adverse events in patients with advanced gastric cancer: A meta-analysis

  2023cites this paper
• Exploring adherence in patients with advanced breast cancer: focus on CDK4/6 inhibitors

  2023cites this paper
• Impact of initiating oral anticancer agents for leukemia on adherence to medications for multiple chronic conditions

  2023cites this paper
• A pilot study of adherence to lenalidomide among older patients with multiple myeloma.

  2023cites this paper
• [Patient Safety Management Practiced by Pharmacy Pharmacists Using Their Training at Oncology Hospital].

  2023cites this paper
• Features of Cancer mHealth Apps and Evidence for Patient Preferences: Scoping Literature Review

  2023cites this paper
• Adherence to Adjuvant Endocrine Therapy and Survival Among Older Women with Early-Stage Hormone Receptor-Positive Breast Cancer

  2023cites this paper
• Implementation of a model integrating primary and oncology pharmacists' care for patients taking oral anticancer agents (OAA)

  2022cites this paper
• Does age play a role in fever and neutropenia events and complications: A comparison of adolescents versus younger children with cancer at a tertiary care pediatric hospital, a pilot project

  2022cites this paper
• A multicentre study with real-world data of the use of palbociclib in the treatment of breast cancer: Treatment duration correlates with dose reductions

  2022cites this paper
• Assessment of compliance with hormonal therapy in early breast cancer patients with positive hormone receptor phenotype: A single institution study

  2022cites this paper
• A prospective study of adherence to lenalidomide for multiple myeloma using Medication Event Monitoring System (MEMS) caps

  2022cites this paper
• ONS Guidelines™ to Support Patient Adherence to Oral Anticancer Medications.

  2022cites this paper
• Adherence to Analgesics Among Outpatients Seriously Ill With Cancer

  2022cites this paper
• Feasibility and Quality Validation of a Mobile Application for Enhancing Adherence to Opioids in Sickle Cell Disease

  2022cites this paper
• Optimizing Adjuvant Treatment Recommendations for Older Women with Biologically Favorable Breast Cancer: Short-Course Radiation or Long-Course Endocrine Therapy?

  2022cites this paper
• Adherence to Hormonal Therapy in Breast Cancer Patients in Saudi Arabia: A Single-Center Study

  2022cites this paper
• Influence of the COVID-19 Pandemic on Adherence to Orally Administered Antineoplastics

  2022cites this paper
• Adherence to oral hormonal anticancer agents in breast cancer

  2022cites this paper
• Digital remote monitoring plus usual care versus usual care in patients treated with oral anticancer agents: the randomized phase 3 CAPRI trial

  2022cites this paper
• Randomized Controlled Pilot Trial of a Low-Touch Remotely-Delivered Values Intervention to Promote Adherence to Adjuvant Endocrine Therapy Among Breast Cancer Survivors.

  2022cites this paper
• Multi-Disciplinary Care Planning of Ovarian Cancer in Older Patients: General Statement—A Position Paper from SOFOG-GINECO-FRANCOGYN-SFPO

  2022cites this paper
• Exploring a New Theoretical Model to Explain the Behavior of Medication Adherence

  2022cites this paper
• Living experiences of patients with advanced cancer with low socioeconomic status: protocol for a systematic review of qualitative evidence

  2022cites this paper
• Pro-adherence complementary audiovisual educational intervention model for chronic myeloid leukemia patients treated with imatinib mesylate

  2022cites this paper
• Improving Cancer Care Through Digital Health Coaching.

  2022cites this paper
• Supportive and Palliative Care for Genitourinary Malignancies

  2022cites this paper
• Facing points of view: Representations on adjuvant endocrine therapy of premenopausal patients after breast cancer and their healthcare providers in France. The FOR-AD study.

  2022cites this paper
• Accuracy of tumor registry versus pharmacy dispensings for breast cancer adjuvant endocrine therapy

  2022cites this paper
• Follow-up and Cancer Survivorship.

  2022cites this paper
• Real World Adherence to and Persistence With Oral Oncolytics in Multiple Myeloma: A Systematic Review and Meta-analysis.

  2022cites this paper
• Defining appropriate quality performance metrics for pharmacies dispensing oral oncology therapies.

  2022cites this paper
• Ascertaining QUAZARs: slow-motion and light-speed development of oral azacitidine and decitabine

  2022cites this paper
• Call to Action for Improving Oral Anticancer Agent Adherence.

  2022cites this paper
• Developing a medication adherence technologies repository: proposed structure and protocol for an online real-time Delphi study

  2022cites this paper
• Home is best. Self-administration of subcutaneous Bortezomib at home in patients with multiple myeloma - A mixed method study.

  2022cites this paper
• [Evaluation of the practice of prescribing oral chemotherapy type "Capecitabine" by medical oncologist: A first study from Morocco].

  2021cites this paper
• TAS-102 Independent and Combined Therapy in Metastatic Colorectal Cancer

  2021cites this paper
• PPA_A_310409 2175..2184

  2021cites this paper
• Influence of the implementation of a multidisciplinary consultation program on adherence to the first ever course of oral antineoplastic treatment in patients with cancer

  2021cites this paper
• Contribution of social and demographic parameters to the long-term survival prognosis of chronic myeloid leukemia patients

  2021cites this paper
• Association between adherence to oral therapies in cancer patients and clinical outcome: A systematic review of the literature

  2021cites this paper
• Prolonged survival in patients with hand-foot skin reaction secondary to cooperative sorafenib treatment

  2021cites this paper
• A Smartphone-Based App to Improve Adjuvant Treatment Adherence to Multidisciplinary Decisions in Patients With Early-Stage Breast Cancer: Observational Study

  2021cites this paper
• Adherence to PARP inhibitor therapy among women with ovarian cancer.

  2021cites this paper
• Assessment of Adherence to Imatinib and Health-Related Quality of Life Among Patients with Gastrointestinal Stromal Tumor: A Cross-Sectional Study in an Oncology Clinic in Malaysia

  2021cites this paper
• Treatment adherence with diclofenac 3% gel among patients with multiple actinic keratoses: an integrated low-intensity intervention program versus standard-of-care.

  2021cites this paper
• Adherence to ruxolitinib, an oral JAK1/2 inhibitor, in patients with myelofibrosis: interim analysis from an Italian, prospective cohort study (ROMEI)

  2021cites this paper
• Systematic review of real-world studies evaluating the impact of medication non-adherence to endocrine therapies on hard clinical endpoints in patients with non-metastatic breast cancer.

  2021cites this paper
• The need for effective digital solutions to enhance adherence to oral anti-cancer medicines in adults: a systematic review of reviews (Preprint)

  2021cites this paper
• Health-related quality of life in patients with acute promyelocytic leukemia: a systematic literature review

  2021cites this paper
• Rationale for once-daily or twice-daily dosing of zanubrutinib in patients with mantle cell lymphoma

  2021cites this paper
• Breast cancer patients' insurance status and residence zip code correlate with early discontinuation of endocrine therapy: An analysis of the ECOG‐ACRIN TAILORx trial

  2021cites this paper
• A mixed method study design to explore the adherence of haematological cancer patients to oral anticancer medication in a multilingual and multicultural outpatient setting: The MADESIO protocol

  2021cites this paper
• Impact of depression on adherence to lenalidomide plus low-dose dexamethasone in patients with relapsed or refractory myeloma

  2021cites this paper
• Adherence to oral antineoplastic agents in pediatric oncology. A multicenter study.

  2021cites this paper
• Treatment Adherence in Patients with Lung Cancer from Prospects of Patients and Physicians

  2021influential citation
• Patients’ Perceived Continuity of Care and Adherence to Oral Anticancer Therapy: a Prospective Cohort Mediation Study

  2021cites this paper
• Teenagers and Young Adults with Cancer: An Exploration of Factors Contributing to Treatment Adherence

  2021influential citation
• Investigation of Intervention Solutions to Enhance Adherence to Oral Anticancer Medicines in Adults: Overview of Reviews

  2021influential citation
• A mixed-methods study of the technical feasibility and patient acceptability of a real-time adherence monitor in breast cancer survivors taking adjuvant endocrine therapy

  2021cites this paper
• The Use of Real-World Evidence for Oral Chemotherapies in Breast Cancer

  2021cites this paper
• Postprandial administration but not controlled release in the colon increases oral bioavailability of DF030263, a promising drug candidate for chronic lymphocytic leukemia.

  2021cites this paper
• Multicriteria decision analysis in health care decision in oncology: a systematic review

  2021cites this paper
• Poor Adherence to Common Recommendations and Associated Factors among Outpatients with Type 2 Diabetes Mellitus in a Police Hospital of Ethiopia

  2021cites this paper
• Comparison of out-of-pocket costs and adherence between the two arms of the prospective, randomized abiraterone food effect trial

  2021cites this paper
• Strategies to improve sorafenib efficacy during image-guided treatment of hepatocellular carcinoma

  2021cites this paper
• Postmarketing safety of anaplastic lymphoma kinase (ALK) inhibitors: an analysis of the FDA Adverse Event Reporting System (FAERS)

  2021cites this paper
• Assessment of potential process quality indicators for systemic treatment of breast cancer in Belgium: a population-based study

  2021cites this paper